Abnormal α-synuclein interactions with rab proteins in α-synuclein A30P transgenic mice

被引:80
|
作者
Dalfó, E
Gómez-Isla, T
Rosa, JL
Bodelón, MN
Tejedor, MC
Barrachina, M
Ambrosio, S
Ferrer, I
机构
[1] Hosp Univ Bellvitge, Serv Anat Patol, Inst Neuropatol, Hosp Llobregat, Barcelona 08907, Spain
[2] Univ Barcelona, Dept Biol Cellular & Anat Patol, Unitat Neuropatol Expt, Barcelona, Spain
[3] Univ Barcelona, Hosp Llobregat, Dept Ciencias Fisiol 2, Unitat Bioquim, Barcelona, Spain
[4] Univ Navarra, Dept Neurol, Navarra, Spain
关键词
alpha-synuclein; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP); Parkinson disease; Rab3a; Rab5; Rab8; rotenone;
D O I
10.1093/jnen/63.4.302
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mutation A30P in the a-synuclein gene is a cause of familial Parkinson disease. Transgenic mice expressing wild mouse and mutant human A30P alpha-synuclein, Tg5093 mice (Tg), show a progressive motor disorder characterized by tremor, rigidity, and dystonia, accompanied by accumulation of alpha-synuclein in the soma and neurites and by a conspicuous gliosis beginning in the hippocampal formation at the age of 7 to 8 months and spreading throughout the CNS. Impaired short-term changes in synaptic strength have also been documented in hippocampal slices from Tg mice. alpha-synuclein aggregates of approximately 34 and 70 kDa, in addition to the band of 17 kDa, corresponding to the molecular weight of a-synuclein, were recovered in the PBS-soluble fraction of brain homogenates from Tg mice but not from brain samples from age-matched wildtype littermates. MPTP-treated Tg and wildtype mice produced alpha-synuclein aggregates in the PBS-, deoxycholate-, and SDS-soluble fractions. Aggregates of alpha-synuclein, although with different molecular weights, were also observed in rotenone-treated Tg and wildtype mice. Pull-down studies with members of the Rab protein family have shown that a-synuclein from Tg mice interacts with Rab3a, Rab5, and Rab8. This binding is not due to the amount of alpha-synuclein (levels of which are higher in Tg mice) and it is not dependent on the amount of Rab protein used in the assay. Rather, alpha-synuclein interactions with Rab proteins are due to mutant (x-synuclein as demonstrated in Rab pull-down assays with recombinant of wildtype and mutant A30P human alpha-synuctein. Since Rab3a, Rab5, and Rab8 are important proteins involved in synaptic vesicle trafficking and exocytosis at the synapse, vesicle endocytosis, and trans-Golgi transport, respectively, it can be suggested that these functions are impaired in Tg mice. This rationale is consistent with previous data showing that short-term hippocampal synaptic plasticity is altered and that a.-synuclein accumulates in the cytoplasm of neurons in Tg mice.
引用
收藏
页码:302 / 313
页数:12
相关论文
共 50 条
  • [31] Motor impairment and aberrant production of neurochemicals in human α-synuclein A30P+A53T transgenic mice with α-synuclein pathology
    Ikeda, Masaki
    Kawarabayashi, Takeshi
    Harigaya, Yasuo
    Sasaki, Atsushi
    Yamada, Shuichi
    Matsubara, Etsuro
    Murakami, Tetsuro
    Tanaka, Yuya
    Kurata, Tomoko
    Wuhua, Xu
    Ueda, Kenji
    Kuribara, Hisashi
    Ikarashi, Yasushi
    Nakazato, Yoichi
    Okamoto, Koichi
    Abe, Koji
    Shoji, Mikio
    BRAIN RESEARCH, 2009, 1250 : 232 - 241
  • [32] Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein
    Marxreiter, Franz
    Nuber, Silke
    Kandasamy, Mahesh
    Klucken, Jochen
    Aigner, Robert
    Burgmayer, Ralf
    Couillard-Despres, Sebastien
    Riess, Olaf
    Winkler, Jurgen
    Winner, Beate
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2009, 29 (05) : 879 - 890
  • [33] A30Pα-synuclein原核表达载体的构建及表达
    周英泽
    王桂芬
    刘江月
    张代娟
    刘同美
    济宁医学院学报, 2012, 35 (02) : 97 - 99
  • [34] Interactions between the Intrinsically Disordered Proteins β-Synuclein and α-Synuclein
    Williams, Jonathan K.
    Yang, Xue
    Baum, Jean
    PROTEOMICS, 2018, 18 (21-22)
  • [35] Intracranial administration of alpha-synuclein fibrils in A30P-synuclein transgenic mice causes robust synucleinopathy and microglial induction
    Gentzel, Renee C.
    Toolan, Dawn
    Jinn, Sarah
    Schachter, Joel B.
    Ma, Lei
    Kahle, Philipp J.
    Smith, Sean M.
    Marcus, Jacob N.
    NEUROBIOLOGY OF AGING, 2021, 106 : 12 - 25
  • [36] Structures and Free Energy Landscapes of the Wild-Type and A30P Mutant-Type α-Synuclein Proteins with Dynamics
    Wise-Scira, Olivia
    Aloglu, Ahmet Kemal
    Dunn, Aquila
    Sakallioglu, Isin Tuna
    Coskuner, Orkid
    ACS CHEMICAL NEUROSCIENCE, 2013, 4 (03): : 486 - 497
  • [37] Familial parkinsonism with synuclein pathology -: Clinical and PET studies of A30P mutation carriers
    Krüger, R
    Kuhn, W
    Leenders, KL
    Sprengelmeyer, R
    Müller, T
    Woitalla, D
    Portman, AT
    Maguire, RP
    Veenma, L
    Schröder, U
    Schöls, L
    Epplen, JT
    Riess, O
    Przuntek, H
    NEUROLOGY, 2001, 56 (10) : 1355 - 1362
  • [38] Trypsin disrupts the trafficking of the human dopamine transporter by α-synuclein and its A30P mutant
    Wersinger, C
    Vernier, P
    Sidhu, A
    BIOCHEMISTRY, 2004, 43 (05) : 1242 - 1253
  • [39] First Appraisal of Brain Pathology Owing to A30P Mutant Alpha-Synuclein
    Seidel, Kay
    Schoels, Ludger
    Nuber, Silke
    Petrasch-Parwez, Elisabeth
    Gierga, Kristin
    Wszolek, Zbigniew
    Dickson, Dennis
    Gai, Wei P.
    Bornemann, Antje
    Riess, Olaf
    Rami, Abdelhaq
    den Dunnen, Wilfried F. A.
    Deller, Thomas
    Rueb, Udo
    Krueger, Rejko
    ANNALS OF NEUROLOGY, 2010, 67 (05) : 684 - 689
  • [40] Wildtype and A30P Mutant Alpha-Synuclein Form Different Fibril Structures
    Nielsen, Soren Bang
    Macchi, Francesca
    Raccosta, Samuele
    Langkilde, Annette Eva
    Giehm, Lise
    Kyrsting, Anders
    Svane, Anna Sigrid Pii
    Manno, Mauro
    Christiansen, Gunna
    Nielsen, Niels Christian
    Oddershede, Lene
    Vestergaard, Bente
    Otzen, Daniel Erik
    PLOS ONE, 2013, 8 (07):